Tisagenlecleucel Vs Standard of Care As Second-Line Therapy of Primary Refractory or Relapsed Aggressive B-Cell Non-Hodgkin Lymphoma: Analysis of the Phase III Belinda Study

被引：11

作者：

Bishop, Michael R. ^{[1
]}

Dickinson, Michael ^{[2
,3
]}

Purtill, Duncan ^{[4
]}

Barba, Pere ^{[5
,6
]}

Santoro, Armando ^{[7
,8
]}

Hamad, Nada ^{[9
,10
]}

Kato, Koji ^{[11
]}

Sureda, Anna ^{[12
]}

Greil, Richard ^{[13
,14
]}

Thieblemont, Catherine ^{[15
]}

Morschhauser, Franck ^{[16
]}

Janz, Martin ^{[17
]}

Flinn, Ian W. ^{[18
]}

Rabitsch, Werner ^{[19
]}

Kwong, Yok Lam ^{[20
]}

Kersten, Marie Jose ^{[21
]}

Minnema, Monique C. ^{[22
]}

Holte, Harald ^{[23
]}

Chan, Esther Hian Li ^{[24
]}

Martinez-Lopez, Joaquin ^{[25
]}

Mueller, Antonia M. S. ^{[26
]}

Maziarz, Richard T. ^{[27
]}

McGuirk, Joseph P. ^{[28
]}

Bachy, Emmanuel ^{[29
,30
]}

Le Gouill, Steven ^{[31
,32
]}

Dreyling, Martin ^{[33
]}

Harigae, Hideo ^{[34
]}

Bond, David A. ^{[35
]}

Andreadis, Charalambos ^{[36
]}

McSweeney, Peter A. ^{[18
]}

Kharfan-Dabaja, Mohamed A. ^{[37
,38
]}

Newsome, Simon ^{[39
]}

Degtyarev, Evgeny ^{[39
]}

Del Corral, Chris ^{[40
]}

Andreola, Giovanna ^{[39
]}

Masood, Aisha ^{[40
]}

Schuster, Stephen J. ^{[41
]}

Jaeger, Ulrich ^{[42
]}

Borchmann, Peter ^{[43
]}

Westin, Jason R. ^{[44
]}

机构：

[1] Univ Chicago, David & Etta Jonas Ctr Cellular Therapy, Chicago, IL 60637 USA

[2] Univ Melbourne, Peter MacCallum Canc Ctr, Melbourne, Vic, Australia

[3] Univ Melbourne, Royal Melbourne Hosp, Melbourne, Vic, Australia

[4] Fiona Stanley Hosp, Murdoch, WA, Australia

[5] Hosp Univ Vall dHebron, Barcelona, Spain

[6] Univ Autonoma Barcelona, Barcelona, Spain

[7] Humanitas Univ, Dept Biomed Sci, Milan, Italy

[8] IRCCS Humanitas Res Hosp, Humanitas Canc Ctr, Milan, Italy

[9] St Vincents Hosp Sydney, Dept Haematol, Sydney, NSW, Australia

[10] Univ New South Wales, St Vincents Clin Sch, Sydney, NSW, Australia

[11] Kyushu Univ Hosp, Hematol Oncol & Cardiovasc Med, Fukuoka, Japan

[12] Inst Catala Oncol Hospitalet de Llobregat, Clin Hematol Dept, Barcelona, Spain

[13] Paracelsus Med Univ, Salzburg Canc Res Inst, Med Dept 3, CCCIT, Salzburg, Austria

[14] Canc Cluster Salzburg, Salzburg, Austria

[15] Hop St Louis, AP HP, Hematooncol, Paris, France

[16] Ctr Hosp Reg Univ Lille, Lille, France

[17] Univ Hosp Berlin, Hematol Oncol & Tumorimmunol, Charite, Campus Benjamin Franklin, Berlin, Germany

[18] Sarah Cannon Res Inst Tennessee Oncol, Nashville, TN USA

[19] Med Univ Vienna, Internal Med 1, BMT Unit, Vienna Gen Hosp, Vienna, Austria

[20] Queen Mary Hosp, Dept Med, Hong Kong, Peoples R China

[21] Univ Amsterdam, Amsterdam UMC, Dept Hematol, Amsterdam, Netherlands

[22] Univ Med Ctr Utrecht, Dept Med Oncol, Utrecht, Netherlands

[23] Oslo Univ Hosp, Dept Oncol, Oslo, Norway

[24] Natl Univ Canc Inst, Singapore, Singapore

[25] Univ Complutense Madrid, Hosp 12 Octubre, CNIO, Madrid, Spain

[26] Univ Hosp Zurich, Dept Med Oncol & Hematol, Zurich, Switzerland

[27] Oregon Hlth & Sci Univ, Knight Canc Inst, Ctr Hematol Malignancies, Portland, OR 97201 USA

[28] Univ Kansas, Ctr Canc, Div Hematol Malignancies & Cellular Therapeut, Westwoon, KS USA

[29] Hosp Civils Lyon, Lyon, France

[30] Univ Claude Bernard Lyon 1, Lyon, France

[31] INSERM, CRCINA, Nantes, France

[32] Nantes Med Univ, Nantes, France

[33] LMU Klinikum, Med Klin 3, Munich, Germany

[34] Tohoku Univ Hosp, Sendai, Miyagi, Japan

[35] Ohio State Univ, Columbus, OH 43210 USA

[36] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA

[37] Mayo Clin, Div Hematol Oncol & Blood & Marrow Transplantat, Jacksonville, FL 32224 USA

[38] Mayo Clin, Cellular Therapy Program, Jacksonville, FL 32224 USA

[39] Novartis Pharma AG, Basel, Switzerland

[40] Novartis Pharmaceut, E Hanover, NJ USA

[41] Univ Penn, Abramson Canc Ctr, Lymphoma Program, Philadelphia, PA 19104 USA

[42] Med Univ Vienna, Clin Div Hematol & Hemostaseol, Dept Med 1, Vienna Gen Hosp, Vienna, Austria

[43] Univ Hosp Cologne, Clin Internal Med 1, Cologne, Germany

[44] Univ Texas MD Anderson Canc Ctr, Dept Lymphoma & Myeloma, Houston, TX 77030 USA

来源：

BLOOD | 2021年 / 138卷

关键词：

D O I：

10.1182/blood-2021-155068

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：6